November 20, 20203 min read, 631 words
Published: November 20, 2020 | 3 min read, 631 words
By BRUSSELS (Reuters) - The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.The bloc has agreed to pay 15.50 euros ($...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.